Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
The closing price of Purple Biotech Ltd ADR (NASDAQ: PPBT) was $0.78 for the day, down -45.07% from the previous closing price of $1.42. In other words, the price has decreased by -$45.07 from its previous closing price. On the day, 47.01 million shares were traded. PPBT stock price reached its highest trading level at $0.9153 during the session, while it also had its lowest trading level at $0.715.
Ratios:
Our analysis of PPBT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.88 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PPBT now has a Market Capitalization of 2705952 and an Enterprise Value of 421078304.
Stock Price History:
The Beta on a monthly basis for PPBT is 0.75, which has changed by -0.9135255 over the last 52 weeks, in comparison to a change of 0.20221436 over the same period for the S&P500. Over the past 52 weeks, PPBT has reached a high of $13.95, while it has fallen to a 52-week low of $1.27. The 50-Day Moving Average of the stock is -65.65%, while the 200-Day Moving Average is calculated to be -72.65%.
Shares Statistics:
PPBT traded an average of 111.09K shares per day over the past three months and 4806300 shares per day over the past ten days. A total of 3.03M shares are outstanding, with a floating share count of 3.03M. Insiders hold about 0.10% of the company’s shares, while institutions hold 1.89% stake in the company. Shares short for PPBT as of 1755216000 were 103149 with a Short Ratio of 0.93, compared to 1752537600 on 132633. Therefore, it implies a Short% of Shares Outstanding of 103149 and a Short% of Float of 4.0.
Earnings Estimates
The current market rating for Purple Biotech Ltd ADR (PPBT) reflects the collective analysis of 1.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.52, with high estimates of -$0.52 and low estimates of -$0.52.
Analysts are recommending an EPS of between -$1.16 and -$1.16 for the fiscal current year, implying an average EPS of -$1.16. EPS for the following year is -$0.62, with 1.0 analysts recommending between -$0.62 and -$0.62.
